about
Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA functionGene network and pathway analysis of mice with conditional ablation of Dicer in post-mitotic neuronsTau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domainSynphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent mannerMicroRNAs targeting Nicastrin regulate Aβ production and are affected by target site polymorphismsIncreased LINGO1 in the cerebellum of essential tremor patients.Protein folding diseases and neurodegeneration: lessons learned from yeast.ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.MicroRNAs in Alzheimer's disease.MicroRNAs and Alzheimer's Disease Mouse Models: Current Insights and Future Research Avenues.miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer's diseasePhosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson.Accumulation of amyloid-β in the cerebellar cortex of essential tremor patients.Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs.Identification of a functional FADS1 3′UTR variant associated with erythrocyte n-6 polyunsaturated fatty acids levels
P50
Q21202833-94C4AA55-BF55-43C3-8463-929130ADDCBFQ28592712-EEA909BC-0231-4C91-8754-CFE4B691320EQ30009097-D1DCB739-C0CC-4F79-9720-5C8A7B43E739Q33742140-D63BFF57-5613-45D7-A591-0552171DCC7AQ33920169-CD673142-EA52-46EC-8597-E14969C0DB61Q34039911-7345467F-A278-411B-8FCC-7EB6367498E0Q37094131-24FD9D7C-8B3F-4783-B823-81A26892C000Q37149914-4E90C915-F589-4F2C-A68E-9695CB9C9768Q37979612-D80BC391-2FB7-4C7B-BCBD-3E751234B83EQ39719620-253292ED-5780-44BB-8CFC-D1F7D2C25246Q39742529-3F3403AC-93E3-488E-BEB9-0470A7EE652BQ46478232-1B83F641-5AC9-43C1-BF42-7663FBA3FA8BQ50244475-427DC27D-D993-4510-840F-B61A176FA81FQ51154144-CD81AFF8-7503-46B2-B7B3-EF43A3CC1765Q53314394-3BCE4C13-CBBE-4177-99AF-4A91466C79CFQ57605576-801F4BAF-914E-4D11-B8AA-CD1B62D45787
P50
description
chercheuse en pharmacologie
@fr
name
Charlotte Delay
@ast
Charlotte Delay
@es
Charlotte Delay
@fr
Charlotte Delay
@nl
type
label
Charlotte Delay
@ast
Charlotte Delay
@es
Charlotte Delay
@fr
Charlotte Delay
@nl
prefLabel
Charlotte Delay
@ast
Charlotte Delay
@es
Charlotte Delay
@fr
Charlotte Delay
@nl
P106
P2038
Charlotte_Delay